A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial
Christopher W. Lee, Karl Bélanger, Sanjay C. Rao, Teresa M. Petrella, Richard G. Tozer, Lori Wood, Kerry J. Savage, Elizabeth A. Eisenhauer, Timothy W. Synold, Nancy Wainman, Lesley SeymourVolume:
26
Language:
english
Pages:
7
DOI:
10.1007/s10637-007-9097-9
Date:
June, 2008
File:
PDF, 145 KB
english, 2008